Brenda Acosta Ashby
Endocrinology, Diabetes & Metabolism · Doral, FLNPI 1366480386
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $102,526 of the $116,834 with a category attached, or 87.8%. 18 manufacturers reported payments, led by AstraZeneca at 52.9% of the total. Reporting peaked in 2019 at $95,677 and has fallen 99.9% since, to $120 in 2025. Among endocrinology, diabetes & metabolism clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 223 payments — averaging $523.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$62K
- Sanofi-aventis U.S. LLC$29K
- Merck$19K
- Lilly USA, LLC$3K
- Boehringer Ingelheim$2K
- Johnson & Johnson$811
- plus $1K from 12 others
What the payments were for
- Consulting fees$2,9253%
- Speaking & faculty fees$102,52688%
- Travel & lodging$5,2384%
- Food & beverage$6,1145%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 78 | $61,750 |
| Sanofi-aventis U.S. LLC | 47 | $29,245 |
| Merck | 34 | $18,736 |
| Lilly USA, LLC | 21 | $3,291 |
| Boehringer Ingelheim | 11 | $1,728 |
| Johnson & Johnson | 7 | $811 |
| Amneal Pharmaceuticals LLC | 3 | $550 |
| Novo Nordisk | 9 | $365 |
| AbbVie | 2 | $133 |
| IBSA Pharma Inc. | 2 | $42 |
| Abbott | 2 | $41 |
| Radius Health, Inc. | 1 | $33 |
| Senseonics, Incorporated | 1 | $22 |
| Lifescan, Inc. | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Mannkind Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$116,834 in reported general payments places this provider in the 90th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metformin Hcl | 14 | $86 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Doral
- Krista GonzalesDoral$85K
- Jay SkylerMiami$2.2M
- Arelis MaderaPort Charlotte$1.7M
- Damon TantonOrlando$1.2M
- Gaston PonteMelbourne$906K
- Brian LakeLargo$888K
- David SuttonJacksonville$783K
- Mae Sheikh AliJacksonville$751K
- Richard PratleyOrlando$735K
- Lee MetchickDeland$728K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.